Growing demand for pediatric endocrinology services, improved diagnostic tools, and emerging targeted therapies are propelling the congenital hyperinsulinism treatment market forward, addressing significant unmet needs. https://www.datamintelligence.com/research-report/congenital-hyperinsulinism-treatment-market